Prevalence and risk factors of osteoporosis in diabetic individuals above 50 years of age at a tertiary care hospital: An observational study

Abstract

Background:Diabetes mellitus and osteoporosis coexist in the elderly population. However, there is no conclusive evidence as to whether diabetes affects the progression of osteoporosis in this population. In addition, diabetes-associated systemic complications may also contribute to an increased risk of fracture. Aim: To determine the prevalence and risk factors of osteoporosis in diabetic individuals above 50 years of age and to estimate the burden of the disease in males and females. Methods: A hospital-based cross-sectional, and observational study was conducted in the Department of General Medicine, All India Institute of Medical Sciences, Bhubaneswar (AIIMS). A total of 203 diabetic individuals above 50 years of age were recruited in the study, and their bone mineral density (BMD) was evaluated using a dual-energy X-ray absorptiometry scan. Other clinical and biochemical parameters were also assessed. A comparison was conducted among males and females and the three categories of BMD. Results: In our study setting, the overall prevalence of osteoporosis in diabetic individuals above 50 years of age was 40.89%. The prevalence was higher in females (56.5%) compared to males (26%). A higher proportion of individuals (51.6%) in the 71-80 years age group had osteoporosis. Increasing age and the duration of diabetes and menopause (in females) were the significant risk factors, along with serum creatinine and glycated hemoglobin. Conclusion: As there is a high prevalence of osteoporosis among diabetics, screening by assessing the BMD must be done in the elderly population to predict the fracture risk (FRAX score), implement appropriate preventive measures, and initiate treatment. Relevance for patients: Based on our findings, patients with diabetes mellitus are more prone to developing osteoporosis, which in turn increases their likelihood to fracture development. In order to prevent further morbidity, diabetics need special care for maintaining their health through the early detection and prevention of such events.

Keywords

Bone mineral density / T-score / FRAX score / Type 2 diabetes mellitus / Fracture risk

Funding

The authors declare that no funds, grants, or other support were received for the conduct of this study or in preparation of this manuscript.

Conflict of interest

The authors declare that there is no financial or non-financial interest in the present study.

References

[1] Misra A, Gopalan H, Jayawardena R, et al. Diabetes in developing countries. J Diabetes. 2019; 11(7):522-539. doi: 10.1111/1753-0407.12803

[2] Kanis J. Assessment of Osteoporosis at the Primary Health Care Level. Summary Report of a WHO Scientific Group. World Health Organization Collaborating Centre for Metabolic Bone Diseases. Report No.: Technical Report. United Kingdom:University of Sheffield; 2007. Available from: https://frax.shef.ac.uk/frax/pdfs/who_technical_report.pdf [Last accessed on 2024 Sep 01].

[3] Sözen T, Özışık L, Başaran NÇ. An overview and management of osteoporosis. Eur J Rheumatol. 2017; 4(1):46-56. doi: 10.5152/eurjrheum.2016.16011

[4] Abushaikha L, Omran S. A survey of osteoporosis risk factors and practices among Jordanian women. J Int Womens Stud. 2010; 11(4):152-161. doi: 10.1136/jirs.11.4.152

[5] Babhulkar S, Seth S. Prevalence of osteoporosis in India: An observation of 31238 adults. Int J Res Orthop. 2021; 7(2): 362-368. doi: 10.18203/issn.2455-4510

[6] Chinese Medical Association.Guideline for primary care of primary osteoporosis (2019). Chin J Gen Pr. 2020; 19(4): 304-315. doi: 10.3760/cma.j.issn.1674-6397.2020.04.001

[7] Wongdee K, Charoenphandhu N. Osteoporosis in diabetes mellitus: Possible cellular and molecular mechanisms. World J Diabetes. 2011; 2(3):41-48. doi: 10.4239/wjd.v2.i3.41

[8] Adil C, Aydın T, Taşpınar Ö, et al. Bone mineral density evaluation of patients with type 2 diabetes mellitus. J Phys Ther Sci. 2015; 27(1):179-182. doi: 10.1589/jpts.27.179

[9] Xu L, Cheng M, Liu X, Shan P, Gao H. Bone mineral density and its related factors in elderly male Chinese patients with type 2 diabetes. Arch Med Res. 2007; 38(2):259-264. doi: 10.1016/j.arcmed.2006.09.012

[10] Xia J, Zhong Y, Huang G, Chen Y, Shi H, Zhang Z. The relationship between insulin resistance and osteoporosis in elderly male type 2 diabetes mellitus and diabetic nephropathy. Ann Endocrinol (Pairs). 2012; 73(6):546-551. doi: 10.1016/j.ando.2012.05.004

[11] Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am. 2003; 32(1):115-134, 7. doi: 10.1016/S0889-8529(02)00098-0

[12] Imran M, Singh A, Bhardwaj A, Agrawal D. Prevalence of osteoporosis and associated risk factors among postmenopausal women: A cross-sectional study from Northern India. J Midlife Health. 2022; 13(3):206-212. doi: 10.47713/jlh.v13i3.189

[13] Kanis JA. Fracture Risk Assessment Tool, FRAX. Available from: https://frax.shef.ac.uk/frax/tool.aspx?country=9 [Last accessed on 2024 Sep 01].

[14] Aleti S, Pal R, Dutta P, et al. Prevalence and predictors of osteopenia and osteoporosis in patients with type 2 diabetes mellitus: A cross-sectional study from a tertiary care institute in North India. Int J Diabetes Dev Ctries. 2020; 40(2): 262-268. doi: 10.1007/s13410-020-00822-9

[15] Kao WH, Kammerer CM, Schneider JL, Bauer RL, Mitchell BD. Type 2 diabetes is associated with increased bone mineral density in Mexican-American women. Arch Med Res. 2003; 34(5):399-406. doi: 10.1016/S0187-5509(03)00088-1

[16] Palermo A, Tuccinardi D, Defeudis G, et al. BMI and BMD: The potential interplay between obesity and bone fragility. Int J Environ Res Public Health. 2016; 13(6):544. doi: 10.3390/ijerph13060544

[17] Chen P, Li Z, Hu Y. Prevalence of osteoporosis in China: A meta-analysis and systematic review. BMC Public Health. 2016; 16(1):1039. doi: 10.1186/s12889-016-3701-1

[18] Tian L, Yang R, Wei L, et al. Prevalence of osteoporosis and related lifestyle and metabolic factors of postmenopausal women and elderly men: A cross-sectional study in Gansu province, Northwestern of China. Medicine (Baltimore). 2017; 96(43):e8294. doi: 10.1097/MD.0000000000008294

[19] Cui L, Chen L, Xia W, et al. Vertebral fracture in postmenopausal Chinese women: A population-based study. Osteoporos Int. 2017; 28(9):2583-2590. doi: 10.1007/s00198-017-4094-2

[20] Yamaguchi T, Sugimoto T. Bone metabolism and fracture risk in type 2 diabetes mellitus [Review]. Endocr J. 2011; 58(8):613-624. doi: 10.1507/endocrj.EJ11-0147

[21] Fu Y, Xu Y, Chen S, Ouyang Y, Sun G. MiR-151a-3p promotes postmenopausal osteoporosis by targeting SOCS5 and activating JAK2/STAT3 signaling. Rejuvenation Res. 2020; 23(4):313-323. doi: 10.1089/rej.2019.2294

[22] Cohen A, Dempster DW, Recker RR, et al. Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2011; 96(10):3095-3105. doi: 10.1210/jc.2011-1542

[23] Friedrich N, Thuesen B, Jørgensen T, et al. The association between IGF-I and insulin resistance. Diabetes Care. 2012; 35(4):768-773. doi: 10.2337/dc11-1652

[24] Abdulameer SA, Sulaiman SAS, Hassali MAA, Subramaniam K, Sahib MN. Osteoporosis and type 2 diabetes mellitus: What do we know, and what we can do? Patient Prefer Adherence. 2012; 6:435-448. doi: 10.2147/PPA.S30204

[25] Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: The study of osteoporotic fractures. J Bone Miner Res. 1997; 12(2): 283-289. doi: 10.1359/jbmr.1997.12.2.283

[26] He Y, Chen D, Guo Q, Shi P, You C, Feng Y. MicroRNA- 151a-3p functions in the regulation of osteoclast differentiation: Significance to postmenopausal osteoporosis. Clin Interv Aging. 2021; 16:1357-1366. doi: 10.2147/CIA.S327287

[27] Lee JH, Kim JH, Hong AR, Kim SW, Shin CS. Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes. Korean J Intern Med. 2020; 35(6):1432-1442. doi: 10.3904/kjim.2020.036

[28] Głogowska-Szeląg J, Kos-Kudła B, Marek B, Nowak M, Siemińska L. Assessment of selected adipocytokines in obese women with postmenopausal osteoporosis. Endokrynol Pol. 2019; 70(6):478-483. doi: 10.5603/EP.a2019.0048

[29] Etherington J, Harris PA, Nandra D, et al. The effect of weight-bearing exercise on bone mineral density: A study of female ex-elite athletes and the general population. J Bone Miner Res. 1996; 11(9):1333-1338. doi: 10.1002/jbmr.5650110912

[30] Johansson H, Kanis JA, Odén A, et al. A meta-analysis of the association of fracture risk and body mass index in women. J Bone Miner Res. 2014; 29(1):223-233. doi: 10.1002/jbmr.20443

[31] Zernicke R, MacKay C, Lorincz C. Mechanisms of bone remodeling during weight-bearing exercise. Appl Physiol Nutr Metab. 2006; 31(6):655-660. doi: 10.1139/h06-090

[32] Franchimont N, Wertz S, Malaise M. Interleukin-6: An osteotropic factor influencing bone formation? Bone. 2005; 37(5):601-606. doi: 10.1016/j.bone.2005.06.019

[33] Lenchik L, Register TC, Hsu FC, et al. Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone. 2003; 33(4):646-651. doi: 10.1016/S8756-3282(03)00208-5

[34] Oh KW, Lee WY, Rhee EJ, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf). 2005; 63(2):131-138. doi: 10.1111/j.1365-2265.2005.02272.x

[35] Cutrim DM, Pereira FA, Paula FJ, Foss MC. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Braz J Med Biol Res. 2007; 40(2):221-227. doi: 10.1590/S0100-879X2007000200006

[36] Gregorio F, Cristallini S, Santeusanio F, Filipponi P, Fumelli P. Osteopenia associated with non-insulin-dependent diabetes mellitus: What are the causes? Diabetes Res Clin Pract. 1994; 23(1):43-54. doi: 10.1016/0168-8227(94)90059-5

[37] Myong JP, Kim HR, Koo JW, Park CY. Relationship between bone mineral density and moderate to severe chronic kidney disease among general population in Korea. J Korean Med Sci. 2013; 28(4):569-574. doi: 10.3346/jkms.2013.28.4.569

[38] Schutte JE, Longhurst JC, Gaffney FA, Bastian BC, Blomqvist CG. Total plasma creatinine: An accurate measure of total striated muscle mass. J Appl Physiol. 1981; 51(3):762-766. doi: 10.1152/jappl.1981.51.3.762

[39] Chen S, Zhou S, Chen Y, Liu R. Association between serum creatinine and osteoporosis in early postmenopausal women: A cross-sectional study. Clin Exp Obstet Gynecol. 2024; 51(2):46. doi: 10.31083/j.ceog5102046

[40] Favarato MHS, Almeida MFD, Lichtenstein A, Martins MDA, Junior MF. Risk of osteoporotic fracture in women using the FRAX tool with and without bone mineral density score in patients followed at a tertiary outpatient clinic-an observational study. Clinics (Sao Paulo). 2022;77:100015. doi: 10.6061/clinics/2022/e100015

[41] Simpkins RC, Downs TN, Lane MT. FRAX prediction with and without bone mineral density testing. Fed Pract. 2017; 34(5):40-43. doi: 10.1002/ehf2.12468